Updates in the Management of Graves Disease in Children

Graves disease (GD) is the primary cause of hyperthyroidism in children. The standard management options—namely, antithyroid drugs (ATD), radioactive iodine, and surgery—have not changed for many years. Although ATD therapy is often the fir...

Full description

Saved in:
Bibliographic Details
Main Author: Yun Jeong Lee
Format: Article
Language:English
Published: Ewha Womans University College of Medicine 2023-12-01
Series:The Ewha Medical Journal
Subjects:
Online Access:http://www.e-emj.org/archive/view_article?pid=emj-46-s1-31
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850257318790299648
author Yun Jeong Lee
author_facet Yun Jeong Lee
author_sort Yun Jeong Lee
collection DOAJ
description Graves disease (GD) is the primary cause of hyperthyroidism in children. The standard management options—namely, antithyroid drugs (ATD), radioactive iodine, and surgery—have not changed for many years. Although ATD therapy is often the first-line treatment for pediatric patients, the low likelihood of spontaneous remission means that most children will require a more permanent solution. Recent clinical trials and systematic reviews have shed light on the long-term outcomes of ATD therapy, radioactive iodine, and surgical interventions in managing pediatric GD. Additionally, novel therapies aimed at B-cells or the thyroid-stimulating hormone receptor, both implicated in the pathogenesis of GD, are under investigation. However, their definitive role in treating childhood GD has yet to be established. This review will cover the latest developments in the treatment of childhood GD, including information on emerging targeted therapies.
format Article
id doaj-art-2fc004244f32467b8bd62e064bb398aa
institution OA Journals
issn 2234-2591
language English
publishDate 2023-12-01
publisher Ewha Womans University College of Medicine
record_format Article
series The Ewha Medical Journal
spelling doaj-art-2fc004244f32467b8bd62e064bb398aa2025-08-20T01:56:28ZengEwha Womans University College of MedicineThe Ewha Medical Journal2234-25912023-12-0146s110.12771/emj.2023.e31emj-46-s1-31Updates in the Management of Graves Disease in ChildrenYun Jeong LeeGraves disease (GD) is the primary cause of hyperthyroidism in children. The standard management options—namely, antithyroid drugs (ATD), radioactive iodine, and surgery—have not changed for many years. Although ATD therapy is often the first-line treatment for pediatric patients, the low likelihood of spontaneous remission means that most children will require a more permanent solution. Recent clinical trials and systematic reviews have shed light on the long-term outcomes of ATD therapy, radioactive iodine, and surgical interventions in managing pediatric GD. Additionally, novel therapies aimed at B-cells or the thyroid-stimulating hormone receptor, both implicated in the pathogenesis of GD, are under investigation. However, their definitive role in treating childhood GD has yet to be established. This review will cover the latest developments in the treatment of childhood GD, including information on emerging targeted therapies.http://www.e-emj.org/archive/view_article?pid=emj-46-s1-31adolescentchildgraves diseasehyperthyroidismtherapeutics
spellingShingle Yun Jeong Lee
Updates in the Management of Graves Disease in Children
The Ewha Medical Journal
adolescent
child
graves disease
hyperthyroidism
therapeutics
title Updates in the Management of Graves Disease in Children
title_full Updates in the Management of Graves Disease in Children
title_fullStr Updates in the Management of Graves Disease in Children
title_full_unstemmed Updates in the Management of Graves Disease in Children
title_short Updates in the Management of Graves Disease in Children
title_sort updates in the management of graves disease in children
topic adolescent
child
graves disease
hyperthyroidism
therapeutics
url http://www.e-emj.org/archive/view_article?pid=emj-46-s1-31
work_keys_str_mv AT yunjeonglee updatesinthemanagementofgravesdiseaseinchildren